Evaluating patient perspectives on participating in scientific research and clinical trials for the treatment of spinal cord injury by Bahsoun, S et al.
1
Vol.:(0123456789)
Scientific Reports |         (2021) 11:4361  | https://doi.org/10.1038/s41598-021-83211-2
www.nature.com/scientificreports
Evaluating patient perspectives 
on participating in scientific 
research and clinical trials 
for the treatment of spinal cord 
injury
Soukaina Bahsoun1,2,4, Jan‑Herman Kuiper1,2,4, Charlotte H. Hulme1,2, 
Angus J. Armstrong Twigg1,2, Wagih El Masri2, Clive Glass3, Bakul Soni3, Naveen Kumar2, 
Joy Roy Chowdhury2, Aheed Osman2 & Karina T. Wright1,2*
A questionnaire was developed to evaluate patients’ perspective on research aimed at improving 
functions and overcoming complications associated with spinal cord injury (SCI). The first three 
sections were based on published and validated assessment tools. The final section was developed 
to assess participant perspectives on research for SCI. One thousand patients were approached, of 
which 159 participated. Fifty‑eight percent of participants were satisfied with their ‘life as a whole’. 
Two factors could be generated that reflected the variance in the data regarding participants’ life with 
a SCI: “Psychosocial and physical wellbeing” and “Independent living”. The majority of participants 
stated they would be involved in research (86%) or clinical trials (77%). However, the likelihood of 
participation dropped when potential risks of the research/trials were explained. Which participants 
would be willing to participate in research could not be predicted based on the severity of their 
injury, their psychosocial and physical wellbeing or their independent living. Despite participant 
establishment of a life with SCI, our data indicates that individuals strive for improvements in 
function. Participant willingness to be included in research studies is noteworthy and scientists and 
clinicians are encouraged to involve more patients in all aspects of their research.
The development of new treatments and therapies for spinal cord injury (SCI) is an active area of health research. 
The ongoing research into SCI has a definitive aim to improve the quality of life for individuals with SCIs. How-
ever, what in research is important to individuals with SCIs is rarely established and can as a result be overlooked.
A study of 14 patients based around an evidence-based questionnaire found that individuals with SCI may feel 
more capable and autonomous if they access information related to  research1. Furthermore, the study concluded 
that all participants were interested in learning about research and clinical  trials1. Others have ascertained that 
most research questions are formulated within academic institutions where SCI patients themselves have no 
direct involvement; consequently research foci may shift away from fulfilling the needs and the preferences of 
SCI  patients2. Although a harmony exists between the patients’ and researchers’ interests, the study suggests that 
the SCI research community should be more inclusive of patients in order to not only meet their demands but 
also to enlarge the scope of applications when novel knowledge is obtained through  research2.
A subsequent survey of a SCI population required participants to rank seven bodily functions that are impor-
tant for the improvement of their quality of  life3. The authors suggest that the results of this survey could help 
scientists and clinicians in the field to target an area of research that has a direct effect on SCI patients’ quality of 
life, unlike much current research that is directed towards “curing” SCI while ignoring the need for independence, 
psychological, social and economic life of individuals with  SCI3. Another study suggested that the competen-
cies of individuals with SCIs must be emphasised, and their experiences must be appreciated by researchers and 
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used to formulate research questions with the greatest potential for patient  benefit4. Moreover, this study stresses 
the need for research outcomes that influence patients’ lives (directly or indirectly) within a short  timeframe4.
Together these publications indicate that the opinions, values, expectations and fears of individuals with an 
SCI can be a valuable resource for scientists and clinicians in this field of research but are frequently overlooked. 
Our study aims to ensure that patient opinion is considered in future scientific study and clinical trial develop-
ment. Our specific objectives are to assess (1) the willingness of SCI patients to participate in various types of SCI 
research, and (2) the correlation between their willingness to participate with injury severity, perceived quality 
of life or psychological wellbeing.
Results
Participants. Questionnaires were returned by 159 participants (15.9%). The majority of participants were 
male (114 males cf. 43 females (2 undisclosed)) and their mean age was 45 years ± 18SD (range 20–80). Sixty 
participants were classed as American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A, 18 AIS 
grade B, 28 AIS grade C and 38 AIS grade D on admission with data not being held for the admission scores of 15 
patients. Twenty four patients showed an improvement in their AIS grade at the time of discharge cf. their score 
on admission, the vast majority (58%) of which improved from AIS grade C to grade D. The mean time of injury 
to questionnaire completion was 10 ± 9SD years, with 88.7% having lived with their SCI for two or more years.
Keeping within the ethical constraints of this study, some data was available for inclusion in this report on 
all of the invited participants who had been patients at the MCSI, in terms of demographic information, time 
of injury and neurological grade as assessed using the Frankel classification. This information was used only 
to demonstrate that the patients who returned questionnaires were representative of the invited cohort. In the 
invited cohort, 69% of the participants were males with similar proportions of the participants being male (64%). 
There was a wide age range of participants (at the time of response and time of injury), which again represented 
the invited population (Table 1). Further, individuals participated from all different injury severities (Table 1). 
Individuals participated in the study irrespective of whether they demonstrated an improvement in severity, as 
deemed by one Frankel grade change, from time of injury to time of discharge, again representing the overall 
invited cohort (invited improvers, 9%; participated improvers, 16%).
Participants’ opinions on scientific research, experimental treatments and clinical trials for 
SCI. Participants were receptive to research with 81% stating they would be happy for their medical records 
to be accessed for scientific research. Figure 1a illustrates that the majority of participants would at least “Mildly 
Agree” to donating tissue to research, with the lowest participation coming from the response to donation of 
bone marrow tissue (54.9% mildly agree or more). There was an overarching willingness to participate in all of 
the experimental treatments and clinical trials suggested including the use of human, animal and genetically 
modified tissues and cells (Fig. 1b).
Only in response to having associated risks (tumour formation, infection, neurological worsening of neu-
rology, increased spasticity and increased neuropathic pain) being explained alongside the prospective trial/
treatment did the questionnaire participants’ responses demonstrate a pattern skewed towards a unlikely par-
ticipation (Fig. 2a). Perhaps surprisingly, there was a large number of participants who were willing to be part 
of experimental treatment or a clinical trial NOT first tested on: lab animals in general, primates, rodents, or 
other humans (Fig. 2b).
Participants’ opinions on living with a SCI. The data from the three Craig Handicap Assessment & 
Reporting Technique (CHART) summary scores were not normally distributed, but the other six summary 
scores were. The CHART summary scores for occupation and mobility indicated that at least 75% of participants 
considered themselves having a disability in these areas by scoring below 100, and scoring particularly low on 
the occupation score (Table 2). The Life Satisfaction checklist (LISAT)-11 scores indicated that over half the 
participants (58%) were satisfied with their life as a whole, with sexual life and leisure situation being the aspects 
most people were dissatisfied with (Fig. 3a). The four LISAT-11 summary scores all had a mean value slightly 
above the 50% point of their full range (Table 3). The majority of participants believed that their situation was 
manageable (Fig. 3b and Table 4). Only 25% of the participants scored 12 or less, leaving 75% scoring in the 
upper half of the scale.
Determining whether participant demographics/injury and their opinions on living with SCI 
relates to their willingness to participate in research. Before investigating the correlation of partici-
pants’ characteristics and their opinions on living with SCI with their willingness to participate in research, we 
performed two separate factor analyses to reduce the number of items in the questionnaire to a smaller number 
of independent factors. One factor analysis was performed using the 39 ordinal components in section 4 of the 
questionnaire. A preliminary analysis using the eigenvalue and factor loading criterion resulted in a seven-factor 
pattern, but the seven factors were not meaningfully interpretable. A parallel analysis was therefore performed, 
which suggested retaining five components. The updated factor analysis based on five components contained six 
items (consent to access records, donating saliva, harvesting blood, lumbar puncture, back surgery and placebo) 
that did not belong to any of the factors and we therefore removed them. The remaining five-factor solution was 
interpretable and explained a large percentage (76.2%) of the variance in the data (Suppl. Table 1).
We interpreted the five factors as representing research activities with increasing perceived risk levels or 
reflecting increasing invasiveness, ranging from level 1 (completely safe participation) to level 5 (highest risk). 
Participation level 1 was termed ‘opinion-based research involvement’ and included group meetings, presenta-
tions, postal communications and questionnaires. Participation level 2 was ‘tissue donor involvement’ including 
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donating blood, fat, bone marrow, sperm and harvesting fat, bone marrow and tissue from olfactory bulb. Par-
ticipation level 3 was ‘clinical trial involvement (without risk explained)’, which included the administration of 
cells from various sources, new experimental drugs, electrical stimulation, hypothermic and physical therapy. 
Participation level 4 was ‘clinical trial involvement (without prior testing)’, which represented taking part in clinical 
trials not tested before on other people, lab primates, lab rodents or lab animals. Participation level 5 was ‘clinical 
trial involvement (with risk explained)’ which represented taking part in clinical trials even when associated risks 
i.e. tumour formation, infection, neurological worsening, increased spasticity and increased neuropathic pain 
were explained. Participation level 3 represented by far the largest amount of variance (46%) of the data, whereas 
the other four levels explained less than 10% each (Suppl. Table 1). Using the factor loadings, we determined the 
theoretical range for each of the five factors and their values for each participant. The median scores were well 
above the midway point for the lowest three levels, suggesting that the majority of participants were willing to 
participate in research at these levels. However, the median score was only slightly above the midway point at 
the fourth level and clearly below the midway point at the highest level, indicating that participants were more 
hesitant to participate at the highest perceived risk levels.
Spearman analysis was used to assess internal correlations of the nine summary scores on life with SCI, which 
all correlated significantly with each other (range of r 0.16–0.68) A factor analysis was performed, resulting in a 
two-factor pattern that explained 64.0% of the total variance in the data (Suppl. Table 2). The first factor consisted 
of spare time, life as a whole, manageability, provision, health and closeness and was entitled “Psychosocial and 
physical wellbeing”. The second factor encompassed physical independence, occupation and mobility and was 
labelled “Independent living”.
Table 1.  Demographic and injury information of individuals who were invited and who participated in the 





Male 64 (67) 69 (346)
Age at time of questionnaire completion (years)
 > 20–< 30 3 (3) 6 (29)
 > 30–< 40 15 (16) 11 (54)
 > 40–< 50 18 (19) 18 (89)
 > 50–< 60 27 (28) 27 (135)
 > 60–< 70 18 (19) 19 (93)
 > 70–< 80 13 (14) 12 (62)
 > 80–< 90 5 (5) 6 (29)
Unknown 1 (1) 1 (0)
Age at time of SCI (years)
 < 20 8 (8) 10 (51)
 > 20–< 30 25 (26) 24 (122)
 > 30–< 40 13 (14) 14 (72)
 > 40–< 50 15 (16) 15 (77)
 > 50–< 60 13 (14) 14 (72)
 > 60–< 70 11 (11) 8 (39)
 > 70–< 80 11 (11) 7 (34)
 > 80–< 90 0 (0) 2 (8)
Unknown 4 (4) 5 (24)
Years since SCI (years)
 < 2 3 (3) 4 (20)
 > 2–< 5 20 (21) 19 (97)
 > 5–< 10 23 (24) 19 (93)
 > 10–< 20 31 (32) 26 (131)
 > 20–< 30 8 (8) 15 (73)
 > 30–< 40 9 (9) 11 (55)
 > 40 1 (1) 1 (4)
Unknown 6 (6) 5 (26)
Injury severity on admission (Frankel)
A 50 (52) 49 (243)
B 18 (19) 14 (69)
C 24 (25) 28 (140)
D 4 (4) 4 (21)
Other/unknown 4 (4) 5 (26)
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Scores for each participant were calculated for the two factors representing life with SCI, based on the loading 
of items in each factor, and used to examine how willingness to participate related to the participants’ demog-
raphy, level of injury and opinion on life with SCI (Table 5). No correlations were observed between the factors 
relating to participant general wellbeing and independent living and their willingness to participate. There was a 
negative correlation between sensory ASIA score and participation level 3 (clinical trial involvement (without risk 
explained)) (p < 0.01; Table 5). The participant demographics which had the greatest impact on the participants 
willingness to participate in research was age, which correlated (negatively) with participation level 1 (p < 0.05; 
Table 5), participation level 2 (p < 0.01; Table 5), participation level 3 (p < 0.05; Table 5) and (positively) with 
participation level 5 (p < 0.05; Table 5). Age of the participants, as well as being female, also negatively correlated 
with psychosocial and physical wellbeing and independent living factors (p < 0.001; Table 5).
Within each group of factors (willingness to participate and opinion on life with SCI) significant correlations 
were also found. The five levels of research participation all correlated significantly with each other, as did the 
psychosocial and physical wellbeing and independent living and factors (p < 0.001; Table 5).
Discussion
The importance of patient participation in research has been acknowledged by research institutions and policy 
makers for some  time5. Our questionnaire was specifically designed to try to address a gap that we identified 
through our own translational SCI research programme. Our results demonstrate a strong willingness of per-
sons with SCI to participate in research, further underlining the importance of involving SCI patients’ directly. 
The overall response rate of 15.9% was disappointingly low, however our analysis of the invited vs. participated 
population indicates that our cohort was representative of the whole. The reason for this low return rate we feel 
is due to the constraints imposed on recruitment into the study by our ethical review board, who decided that 
we were only permitted to approach a potential participant once by post.
Participants responded that they would be willing to participate in all aspects of research. However, a shift 
towards lower numbers was noted in the participants willingness to participate in trials of treatments that had 
not been tested before, and a marked shift if the trials involved significant potential health risks. This decrease in 
willingness to participate in research when there was a perceived risk is not surprising. Nevertheless, the majority 
of participants would still agree to take part in research not first tested on animals or other humans. This could 
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Figure 1.  (a) Bar graph displaying participant responses to the statement: “I would like to be more involved in 
scientific research, including donating the following for research purposes:” (b) Bar graph displaying participant 
responses to the statement: “I would consider taking part in an experimental treatment or clinical trial that 
involved the use of ”.
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be related to a general critical position in relation to animal testing, but we did not investigate the participants’ 
general stance on animal experimentation. We also observed that participants were “very unlikely” to be involved 
in treatments which carried an increased risk of worsening aspects of their morbidity. A 2018 study 6 displayed 
a significant correlation between increased spasticity and decreased quality of life scores, which supports our 
finding that when the possibility of spasticity is explained, the majority of participants felt this potential risk 
would not outweigh the potential benefits of taking part in a trial.
Most participants in our study were satisfied or very satisfied with their life as a whole and various aspects of 
their life, but not with their sexual life, where the vast majority (both genders) were not satisfied. These findings 
are almost exactly the same as those seen in earlier comparable  studies7,8. The degree of disability reported by our 
participants also matches data reported earlier, including the low scores observed in relation to occupation and 
physical  independence7. In 2006, people with SCI in the UK reported markedly higher degrees of disability in 
the domain of physical independence than those in Germany, Australia and  Switzerland7. Our results therefore 
suggest that physical independence of people with SCI in the UK has not improved in the intervening years. 
Finally, our participants reported the same high level of perceived manageability of their situation as found in 
an earlier study with a similar  population7.
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Figure 2.  (a) Bar graph showing participant response to the question: “If the following risk of a treatment was 
explained to you by a clinician before volunteering for an experimental treatment or clinical trial, how likely 
would you be to take part?”. (b) Bar graph showing participant response to the statement: “I would be prepared 
to take part in an experimental treatment of clinical trial which had NOT first been tested on”.
Table 2.  Percentile range of the three summary scores based on CHART.
Percentile range 25th 50th 75th 100th
Occupation score 10.6 42.5 95 100
Physical independence score 4 72 100 100
Mobility score 58 79 99 100
6
Vol:.(1234567890)
Scientific Reports |         (2021) 11:4361  | https://doi.org/10.1038/s41598-021-83211-2
www.nature.com/scientificreports/
Overall, 89% of participants in our study had been living with their injury for more than 2 years and our 
data suggests there is a good level of life satisfaction and a high level of manageability in our participant cohort. 
However, participants felt clearly disadvantaged when it came to physical independence and occupation. This 
separation between general (psychosocial and physical) wellbeing and independent living was mirrored in our 
factor analysis, which suggests these two aspects of life with SCI are largely independent. Nevertheless, we found 
that both correlated negatively with age and being female. The negative influence of age corresponds to earlier 
work, which also found that SCI patients reported lower levels of life satisfaction and physical health, and physical 
independence and occupation function, with increasing  age9. Likewise, earlier work also found that female SCI 
patients reported lower living circumstances, mental health and satisfaction with  health10.
Even though most participants appeared to be satisfied with their life and ability to manage, their readiness 
to be involved in research was strongly affirmative. We found no evidence for a correlation between independent 
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Situation feels manageable
I have learnt skills to cope mostly
I am able to take part in activities I find enjoyable/ rewarding
Supported by the people around me
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Figure 3.  Participants’ responses on a Likert scale to questions about how they feel about their life in general. 
(a) Proportion of each response of the total number of responses about satisfaction with different aspects of life. 
(b) Proportion of different responses about how participants feel about their SCI.
Table 3.  Mean and SD f scores based on LISAT-11.
Score Mean (SD)
Provision 5.8 (2.0)
Spare time 6.3 (2.1)
Closeness 8.5 (3.0)
Health 8.0 (2.8)
Table 4.  Mean, standard deviation and quartiles of the Manageability score based on PMnac.
Score Mean (SD) Range 25th 50th 75th
Manageability 15.0 (3.7) 4–20 12 15 18
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living or psychosocial and physical wellbeing scores and willingness to participate at any of the perceived risk 
levels. We also found no evidence for a correlation between willingness to participate and injury status as meas-
ured by the ASIA scores, other than a weak negative correlation between sensory score and willingness at level 
3. Willingness to participate at level 3 represented almost half the total variation in our data, which probably 
explains why it was the only level demonstrating some correlation. The negative correlation suggests that people 
with better sensory scores are less willing to participate. However, the correlation was weak. The five levels of 
participation that we distinguished provide clues regarding how much an individual is willing to participate 
in research (with or without perceived risk). All levels of participation correlated positively and strongly with 
each other, which would suggest the existence of an overarching second-order factor “willingness to participate 
in research”.
Our study aims to assist in bridging the gap for scientists and clinicians from the bedside-to-bench by audit-
ing the opinion of those patients most likely to benefit from many of the proposed interventions currently under 
development and being translated into the clinical setting. We conclude that individuals with SCI are interested 
in new research provided they are given an informed choice and are willing to participate provided the health 
risks are not too high and that researchers must involve patients more actively, providing contact between the 
research teams and the patients themselves, making research findings more accessible. The assessment strategies 
developed and described in this study will provide valuable tools for assessing the opinion of the SCI patient 
community, which should be evaluated in a larger patient cohort in future studies.
Materials and methods
Study design. We developed a four-section questionnaire (appendix A) in order to evaluate the opinions of 
SCI patients from two UK spinal injury units: The Midland Centre for Spinal Injuries (MCSI) [part 1] and the 
North West Regional Spinal Injuries Centre (NWRSIC) [part 2]. The questions in sections 1, 2 and 3 of the ques-
tionnaire were based on published and validated assessment tools, namely the CHART short  form11, the LISAT-
1112 and the Perceived Manageability Scale (PMnac)13. All questions in section 4 were developed by the authors 
to assess the participants’ opinions on research and novel treatments for SCI. Ethical consent for the study was 
given by the Liverpool Central NRES Committee North West (13/NW/0486). All research was performed in 
accordance with relevant guidelines/regulations, and informed consent was obtained from all participants. The 
postal questionnaire was sent to 1000 individuals who had been admitted to the MCSI or NWRSIC with a SCI 
between 1975 and 2014 and who were chronically injured (more than 12 months past the date of their SCI). 
Questionnaires and consent forms were returned between 2014 and 2016.
Measures. From sections 1, 2 and 3, nine summary scores were calculated for each participant. Question 5 
in section 1 of the questionnaire (based on CHART-SF11) was used to calculate the “Occupation” score. Ques-
tions 1 and 2 in section 2 of the questionnaire (also based on CHART-SF11) were used to calculate the “Physical 
Independence” and “Mobility” scores. Each resulted in a score ranging from 0 (worst) to 100 (best), with scores 
over 100 capped at 100 and implying “no disability”11. Question 1 in section 3 (based on LISAT-1112) had 11 
items and was developed as a checklist of satisfaction with life as a whole and with ten separate domains of life, 
such as health, leisure and sexual  life12. The score on each item ranged from 1 (worst) to 6 (best), and the scores 
on the ten separate domains were summarised using four factors, namely Provision (range 1.6–9.5), Spare time 
(range 1.6–9.8), Closeness (range 2.4–14.3) and Health (2.1–13.0). The second question in section 3 (based on 
 PMnac13) was used to calculate the “Manageability” score, ranging from 5 (worst) to 20 (best). No summary 
scores were calculated from section 4. Instead, descriptive statistics of each answer were presented to assess SCI 
Table 5.  Correlation of injury status (ASIA motor and sensory scores), psychosocial and physical wellbeing 
and independent living with level of willingness to participate in research. AM, ASIA motor score; AS, ASIA 
sensory score; IL, independent living score; PP, psychosocial and physical wellbeing score; L1, participation 
level 1—‘opinion-based research involvement’; L2, participation level 2— ‘tissue donor involvement’; L3, 
participation level 3— ‘clinical trial involvement (without risk explained)’; L4, participation level 4— ‘clinical 
trial involvement (without prior testing)’; and L5, participation level 5—‘clinical trial involvement (with risk 
explained)’. Significance levels: *** < 0.001; ** < 0.01; * < 0.05.
AM AS Gender—female Age PP IL L1 L2 L3 L4 L5
AM 1
AS 0.68*** 1
Gender 0.068 0.186* 1
Age 0.068 0.304*** 0.028 1
PP 0.135 0.112 − 0.733*** − 0.567*** 1
IL − 0.03 0.57 − 0.583*** − 0.476*** 0.411*** 1
L1 − 0.034 − 0.017 0.065 − 0.166* 0.075 0.148 1
L2 − 0.065 − 0.15 − 0.229** -2.960*** 0.021 0.128 0.457*** 1
L3 − 0.107 − 0.216** − 0.152 − 2.036* 0.004 0.067 0.398*** 0.675*** 1
L4 0.117 0.038 − 0.087 0.156 0.088 0.07 0.342*** 0.414*** 0.569*** 1
L5 − 0.032 − 0.091 0.152 0.168* − 0.136 − 0.054 0.256*** 0.517*** 0.505*** 0.465*** 1
8
Vol:.(1234567890)
Scientific Reports |         (2021) 11:4361  | https://doi.org/10.1038/s41598-021-83211-2
www.nature.com/scientificreports/
patients’ opinions on and willingness to participate in various forms of SCI research. Ordinal answers were used 
to analyse the correlation between the above characteristics of SCI patients and opinion on or willingness to 
participate in research.
ISNCSCI is the International Standards for Neurological Classification of Spinal Cord injury. Within the 
ISNCSCI there are neurological scores and grades, including the ASIA motor score and ASIA sensory  score14,15. 
To assess the degree of injury, ASIA scores were obtained for every participant as close as possible to the time of 
questionnaire completion. The motor and sensory numeric scores were used for these analyses.
Missing value imputation. To impute missing data where questions were not completed, particularly in 
the LISAT-11 related sections, a hot deck imputation  macro16 was used in SPSS vs 22 (IBM UK Ltd, Portsmouth, 
UK). Based on correlations among the LISAT-11 items, appropriate decks were chosen. Imputation of missing 
values was conducted in order of the items with the least missing values to the items with the most missing val-
ues. When possible three decks were used, otherwise two decks were used.
Statistical analyses. The results of the survey were summarised using descriptive statistics. Normally dis-
tributed continuous data was summarised as mean (SD), ordinal data as median (IQR) and range, and nominal 
data as frequency and percentage. A correlation analysis was used to analyse whether or not the patients’ views 
on and willingness to participate in scientific research, experimental treatment and trials for SCI correlated with 
their age, gender, SCI status (as measured by sensory and motor ASIA scores) and the patients’ assessment on 
how SCI affected them. Before the correlation analysis, we performed two separate factor analyses (one of the 
nine summary scores from sections 1–3 and one of the 39 ordinal items from section 4 of the questionnaire) to 
obtain a more parsimonious set of independent  factors17. All factors with an eigenvalue greater than 1 and an 
item loading greater than 0.3 were retained, and a Direct Oblimin rotation was used. If the retained factors could 
not be readily interpreted, we used Parallel Analysis to determine the number of factors to be  retained18. All cor-
relation analyses, including the two factor analyses, used Pearson’s correlation coefficient if data was normally 
distributed as judged from QQ-plots, otherwise Spearman’s rank correlation was used. Statistical analyses were 
performed using SPSS 22 (IBM UK Ltd, Portsmouth), R v 3.6.0 (The R Foundation for Statistical Computing, 
Vienna, Austria) and Monte Carlo PCA for Parallel  Analysis19. A 2-sided p-value below 0.05 was assumed to 
denote statistical significance.
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